Tetra Bio-Pharma (TBP:CSE)

Tetra Bio-Pharma

screen-shot-2016-11-17-at-14-23-35Tetra Bio-Pharma (CSE:TBP) (OTCBQ:TBPMF) is a multi subsidiary publicly traded company. They are engaged in the development of Bio Pharmaceuticals and Natural Health Products containing Cannabis and other medicinal plant based elements.

Tetra Bio-Pharma is focused on combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for for inclusion into the existing  bio-pharma industry by regulators, physicians, and insurance companies.

TBP takes the natural aspects of medical cannabis and applies the science of pharma to develop products that patients want, doctors want to prescribe and insurance companies will cover.

Tetra Bio-Pharma has 3 divisions:

Phyto Pain Pharma
A clinical stage research and development company focused on the development of Pharmaceutical products containing plant based Cannabinoids. Phyto Pain Pharma has a pipe line of products currently under development to treat a variety of ailments.

Agro Tek Health
A manufacturing and distribution company focused on acquiring, manufacturing, and distributing registered natural health products.

Grow Pros Cannabis
Focused on Identifying market opportunities in the legal cannabis industry for development of pharmaceutical and over the counter consumer products within the legal cannabis industry. Responsible for cultivation and sourcing of cannabis and industrial hemp on behalf of the TBP family of companies.

CEO Interview

Tetra Bio-Pharma
Web: www.tetrabiopharma.com
Email: investors@tetrabiopharma.com

Momentum Report CSE:TBP

Please wait...

Knowledge is Power

Knowledge is a necessity for all savvy investors. To achieve great CONSISTENT returns, smart investors know they need all the information they can get. We have your information!